Korean Circ J.  2007 Dec;37(12):630-634. 10.4070/kcj.2007.37.12.630.

Comparison of the Clinical and Angiographic Outcomes of Compromised Side Branches (Stent Jail) after Percutaneous Coronary Intervention between Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents

• Lee DW
• Ha JK
• An SG
• Choi JH
• Lee TK
• Lee HC
• Kim J
• Kim JH
• Chun KJ
• Hong TJ
• Shin YW

• KMID: 2227038
• DOI: http://doi.org/10.4070/kcj.2007.37.12.630

Abstract

BACKGROUND AND OBJECTIVES: Drug-eluting stents (DES) have been used worldwide for conducting safe and effective percutaneous coronary intervention (PCI) for treating coronary artery disease. However, the DES might cause a higher frequency of an acute side branch occlusion or stent jails near the target lesion after PCI than that with using bare metal stents (BMS). This may be due to the eluted drug or the thick stent struts. We evaluated the clinical and angiographic outcomes of compromised side branches (stent jail) after PCI and the frequency of side branch occlusion or stent jails between sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES).
SUBJECTS AND METHODS
We analyzed the clinical results and angiographic findings of 47 patients who were treated with a SES and 45 patients who were treated with a PES. We only analyzed the left anterior descending artery (LAD) and its side branches that were more than one millimeter in diameter. Side branch occlusion was defined as the development of total occlusion or a reduction of the thrombolysis in myocardial infarction (TIMI) flow more than grade 1 after stenting. The peak cardiac enzyme levels were measured. We evaluated the clinical outcomes in the hospital and at the 6 month follow up.
RESULTS
There were no significant differences of the baseline clinical demographics between the SES and the PES groups. The total length and diameter of the implanted stents were 42.85+/-15.3 mm vs. 41.68+/-13.3 mm (p=0.93) and 3.09+/-0.3 mm vs. 3.1+/-0.2 mm (p=0.69) in the SES group and PES group, respectively. On average, the number of side branches of the LAD were 2.00+/-0.9 vs. 2.13+/-0.8 and on angiography after stenting, side branch occlusion and reduction of the TIMI developed in 8.51% vs. 13.33% (p=0.46) and 17% vs. 15% (p=0.88) of the SES group and PES group, respectively. The laboratory data showed that the peak creatine kinase-MB (CK-MB) and troponin-I levels were 13.5+/-31 U/L vs. 15.6+/-33 U/L (p=0.77) and 6.3+/-15 ng/mL vs. 5.42+/-9 ng/mL (p=0.77), respectively. There were no clinical in-hospital events for either group. There were no statistically significant differences in major adverse cardiac events (MACEs) at the 6-month follow up (4.3% vs. 8.9%, respectively).
CONCLUSION
The clinical and angiographic outcomes of compromised side branches (stent jail) after PCI and the frequency of side branch occlusion or stent jails between SES and PES were similar.

Keyword

Stents; Complication; Coronary occlusion; Percutaneous transluminal coronary angioplasty

MeSH Terms

Angiography
Angioplasty, Balloon, Coronary
Arteries
Coronary Artery Disease
Coronary Occlusion
Creatine
Demography
Drug-Eluting Stents
Follow-Up Studies
Humans
Myocardial Infarction
Percutaneous Coronary Intervention*
Stents*
Troponin I
Creatine
Troponin I

Reference

1. Lee CH, Tan HC, Bee H, et al. Procedural success and 30-day outcomes between CYPHER™ and TAXUS™ stent implantation for the treatment of bifurcation lesions: a single-center experience. J Invasive Cardiol. 2006. 18:39–42.

2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003. 349:1315–1323.

3. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004. 350:221–231.

4. Fischman DL, Savage MP, Leon MB, et al. Fate of lesion-related side branches after coronary artery stenting. J Am Coll Cardiol. 1993. 22:1641–1646.

5. Pan M, Medina A, Suarez de Lezo J, et al. Follow-up patency of side branches covered by intracoronary Palmaz-Schatz stent. Am Heart J. 1995. 129:436–440.

6. Iniguez A, Macaya C, Alfonso F, Goicolea J, Hernendez R, Zarco F. Early angiographic changes of side branches arising from a Palmaz-Schatz stented coronary segments: results and clinical implications. J Am Coll Cardiol. 1994. 23:911–915.

7. Aliabadi D, Tilli FV, Browers TR, et al. Incidence and angiographic predictors of side branches occlusion following high-pressure intracoronary stenting. Am J Cardiol. 1997. 80:994–997.

8. Bhargava B, Waksman R, Lansky AJ, Kornowski R, Mehran R, Leon MB. Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent. Catheter Cardiovasc Interv. 2001. 54:295–300.

9. Mazur W, Grinstead WC, Hakim AH, et al. Fate of side branches after intracoronary implantation of the Gianturco-Rubin flex-stent for acute or threatened closure after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1994. 74:1207–1210.

10. Kim KH, Jeong MH, Kim NH, et al. Long-term clinical and angiographic outcomes of side branch occlusion after stenting. Korean Circ J. 1999. 29:473–480.

11. Jin QH, Gai LY, Liu HB, Yang TS, Du LS. The influence of coronary main vessel stenting on side branches. Zhonghua Xin Xue Guan Bing Za Zhi. 2005. 33:543–546.

12. Poerner TC, Kralev S, Voelker W, et al. Natural history of small and medium-sized side branches after coronary stents implantation. Am Heart J. 2002. 143:627–635.

13. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000. 35:929–936.

14. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent: immediate and follow-up results. J Am Coll Cardiol. 2000. 35:1145–1151.

15. Choi SY, Tahk SJ, Kim HS, et al. Predictors of side branch occlusion immediately after coronary stenting: an intravascular ultrasound study. Korean Circ J. 2002. 32:655–665.